GlassScriptPhysician profile
Sarah Riley
NPI 1043982853
$1,009.16
in general payments reported to CMS, 2019-2025
19 companies · $30.57 in 2025
The $30.57 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $462 · 2023: $277 · 2024: $49.53 · 2025: $30.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $245.13 | 2021-2024 | |
| Novo Nordisk INC | $128.14 | 2021-2025 | Ozempic, Rybelsus |
| Amgen INC. | $94.83 | 2021-2023 | Repatha |
| Lilly USA, LLC | $77.68 | 2021-2023 | Jardiance, Emgality, Trulicity |
| Astrazeneca Pharmaceuticals LP | $60.01 | 2021-2023 | |
| Corcept Therapeutics | $52.03 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.47 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.22 | 2023 | Jardiance, Tradjenta |
| Amarin Pharma, INC. | $39.84 | 2021 | |
| Dynasplint Systems INC. | $34.97 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.72 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $24.93 | 2022 | |
| Pfizer INC. | $23.42 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $21.62 | 2022 | |
| Eisai INC. | $21.25 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $20.23 | 2023 | Auvelity |
| Merck Sharp & Dohme LLC | $18.45 | 2022 | |
| Glaxosmithkline, LLC. | $15.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.